Stock TSHA TAYSHA GENE THERAPIES, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Official Publications Taysha Gene Therapies, Inc.

Equities

TSHA

US8776191061

Market Closed - Nasdaq
Other stock markets
 04:00:00 2024-04-29 pm EDT 		5-day change 1st Jan Change
2.45 USD +2.51% Intraday chart for Taysha Gene Therapies, Inc. -0.41% +38.42%
Apr. 09 Piper Sandler Initiates Taysha Gene Therapies at Overweight Rating With $9 Price Target MT
Mar. 21 Chardan Adjusts PT on Taysha Gene Therapies to $7 From $5 as Gene Therapy for Rett Syndrome Shows 'Sustained Benefit', Keeps Buy Rating MT

Official Publications

No official publication found

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies
  1. Stock Market
  2. Equities
  3. TSHA Stock
  4. News Taysha Gene Therapies, Inc.
  5. Official Publications